Related Experiment Video
Updated: Aug 10, 2026
Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke,
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA. t.slotkin@duke.edu
Abstract:
Acetylcholine and other neurotransmitters play unique trophic roles in brain development. Accordingly, drugs and environmental toxicants that promote or interfere with neurotransmitter function evoke neurodevelopmental abnormalities by disrupting the timing or intensity of neurotrophic actions. The current review discusses three exposure scenarios involving acetylcholine systems: nicotine from maternal smoking during pregnancy, exposure to environmental tobacco smoke (ETS), and exposure to the organophosphate insecticide, chlorpyrifos (CPF). All three have long-term, adverse effects on specific processes involved in brain cell replication and differentiation, synaptic development and function, and ultimately behavioral performance. Many of these effects can be traced to the sequence of cellular events surrounding the trophic role of acetylcholine acting on its specific cellular receptors and associated signaling cascades. However, for chlorpyrifos, additional noncholinergic mechanisms appear to be critical in establishing the period of developmental vulnerability, the sites and type of neural damage, and the eventual outcome. New findings indicate that developmental neurotoxicity extends to late phases of brain maturation including adolescence. Novel in vitro and in vivo exposure models are being developed to uncover heretofore unsuspected mechanisms and targets for developmental neurotoxicants.
Insights
Neurotoxicants like nicotine and chlorpyrifos disrupt brain development by interfering with acetylcholine signaling, leading to long-term behavioral deficits. Developmental neurotoxicity now includes adolescence, requiring new research models.
Area of Science:
- Neuroscience
- Developmental Biology
- Toxicology
Background:
- Neurotransmitters, particularly acetylcholine, are crucial for normal brain development.
- Exposure to toxicants can disrupt these neurotrophic roles, causing neurodevelopmental abnormalities.
- Developmental neurotoxicity impacts brain cell replication, differentiation, and synaptic function.
Purpose of the Study:
- To review the neurodevelopmental effects of three acetylcholine-disrupting exposure scenarios: maternal smoking (nicotine), environmental tobacco smoke (ETS), and chlorpyrifos (CPF).
- To explore the mechanisms underlying developmental neurotoxicity, including cholinergic and non-cholinergic pathways.
- To highlight recent findings on the extended period of vulnerability into adolescence and emerging research models.
Main Methods:
- Review of existing literature on acetylcholine's role in neurodevelopment.
- Analysis of studies on nicotine, ETS, and chlorpyrifos exposure during critical developmental windows.
- Discussion of cellular and molecular mechanisms of neurotoxicity.
- Consideration of novel in vitro and in vivo models for studying developmental neurotoxicants.
Main Results:
- Nicotine, ETS, and CPF exposure result in long-term adverse effects on brain development and behavior.
- These effects are often linked to disruptions in acetylcholine signaling pathways.
- Chlorpyrifos exhibits additional non-cholinergic mechanisms contributing to its neurotoxicity.
- Developmental neurotoxicity is a concern extending through adolescence.
Conclusions:
- Exposure to common environmental toxicants significantly impacts neurodevelopment through interference with neurotransmitter systems.
- Understanding both cholinergic and non-cholinergic mechanisms is vital for assessing risks.
- Adolescence represents a critical period for neurodevelopmental vulnerability to toxicants.
- Advanced research models are essential for uncovering new mechanisms and targets of developmental neurotoxicants.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:48Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Related Concept Videos
01:23Cholinergic Neurons: Neurotransmission
01:15Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...